Sponsored
Pharma, medical device sectors receive right prescription
Posted
The India-UK FTA is poised to bolster pharmaceutical and medical device supply chains, enhancing access to affordable medicines and fostering collaboration in bulk drugs and joint research. The agreement is expected to boost India's generic drug exports to the UK, currently valued at $1 billion. The medical devices industry anticipates accelerated bilateral trade, emphasizing the need for streamlined regulatory approvals and stricter Rules of Origin checks.
Search
Categories
- National
- International
- Business
- Technology
- Health
- Education
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Read More
Suniel SLAMS 'virtual world' for ruining marriages
Suniel Shetty reflects on changing marriages, emphasizing patience, compromise, and the...
Player auction for second NPL edition scheduled for August 8, 458 players registered
KATHMANDU: The player auction for the second edition of the Nepal Premier League (NPL) will take...
CETA opens duty-free access for Indian seafood; exporters eye 70% growth boost
The India-UK Comprehensive Economic and Trade Agreement (CETA) is set to significantly boost...
India-UK FTA: Trade deal offers tariff safeguards; domestic industry gets protection buffer
India's new trade deal with the UK includes safeguard measures, allowing tariff hikes on British...